Clinical Trial Update: Safety and Efficacy of EVT 101 in Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 trial of EVT 101 for treatment-resistant depression was terminated; the update does not report efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• EVT 101

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depression | Phase 2 | Status: TERMINATED